We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Optimal Nucleic Acid Yields From Archived Tissue

By Biotechdaily staff writers
Posted on 15 Mar 2006
Standard preservation techniques maintain tissue structure but complicate molecular analyses. More...
A kit has been designed to extract total nucleic acids from formaldehyde or paraformaldehyde-fixed, paraffin-embedded (FFPE) tissue.

Retrospective studies of diseased tissue at both the genomic and gene expression level depend on the ability to isolate nucleic acids from archived tissue. Preservation methods employing formaldehyde will keep the tissue structure in good condition and prevent putrefaction, but make it difficult to perform molecular analyses on samples. Nucleic acids are trapped, modified, and can also be fragmented to a degree that is incompatible with many molecular analysis techniques.

A relatively short and simple procedure has been developed to isolate nucleic acids from FFPE tissue. The RecoverAll total nucleic acid isolation kit, a product of Ambion Diagnostics (Woodward, TX, USA), yields nucleic acids that are suitable for quantitative reverse-transcriptase polymerase chain reaction (qRT-PCR), quantitative polymerase chain reaction (qPCR), mutation screening, and microarray analyses. Samples are deparaffinized using a series of xylene and ethanol washes. Next they are subjected to a rigorous protease digestion with an incubation time tailored for the recovery of either RNA or DNA. The nucleic acids are purified using a glass-filter methodology that includes an on-filter nuclease treatment, and are eluted into either water or the low-salt buffer provided. Typical yields of more than 50% that of unfixed tissue from the same sample source can be obtained with the isolation kit.

However, further modification for downstream operations such as microarray analyses, which require purer RNA than that required for qRT-PCR, might be necessary. A longer, 2-day protease digestion time is required to release substantial amounts of DNA, which can then be used for PCR and other downstream applications.


Related Links:
Ambion Diagnostics (Asuragendx)

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Rheumatoid Factors (RF) Test
Rheumatoid Factors (RF)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.